Mead Johnson Nutrition The nutritional products company formed a joint venture with Argentinian dairy producer SanCor Cooperativas Unidas last month to provide products in Argentina. "Management discussed the likelihood that growth would accelerate in Latin America, with infant feeding being under-developed in Peru, Colombia and Ecuador," JPMorgan analysts wrote in a Feb. 22 report. "Brazil is already a top 10 market for MJN, and the company feels there is significant room to grow. Eight of MJN's top 10 markets are in Asia or Latin America, both of which are growing very quickly." Forward Annual Dividend Yield: 1.5% Rated "B- (Buy)" by TheStreet Ratings: The company's fourth-quarter gross profit margin is about the same as it was a year ago. Mead Johnson Nutrition has weak liquidity. Its Quick Ratio is 1, which demonstrates a lack of ability to meet its short-term cash needs. In the fourth quarter, stockholders' net worth increased 51.25% from the prior year. TheStreet Ratings' price target is $100.75. The stock closed Monday at $79.99 and has risen 16.38%.